BCAT
Get informed when a big investor buys or sells
+ FollowOvervalued by 100% based on the discounted cash flow analysis.
| Market cap | $1.67 Billion |
|---|---|
| Enterprise Value | $1.66 Billion |
| Dividend Yield | $3.19 (20.03%) |
| Earnings per Share | $2.09 |
| Beta | 0.77 |
| Outstanding Shares | - |
| P/E Ratio | 7.62 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 18.33%▼ 1.66% |
|---|---|
| Total Invested | $274.57M▼ 8.72% |
| Investors Holding | 100▼ 6.00% |
No data
BlackRock Capital Allocation Trust’s (BCAT) investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust invests in a portfolio of equi...